Microalgae as a source of bioactive molecules – experience from cyanophyte research

By O. Skulberg. Journal of Applied Phycology, 2000

168 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Valuable products from biotechnology of microalgae (2004, background): “Other secondary metabolites are potentially of therapeutical importance, such as antiviral compounds, immunomodulators, inhibitors, or cytostatics (Sivonen and Jones 1999; Skulberg 2000).”
ALGAL TRANSGENICS IN THE GENOMIC ERA 1 (2005, background): “There has been interest in the ‘‘mining’’ of algal species for novel pharmaceuticals (Moore 1999, Skulberg 2000), and in the near future transgenic microalgae may be exploited as cell factories for the production of valuable recombinant products such as vaccines, specialty oils, and novel…”
Sustainability and cyanobacteria (blue-green algae): facts and challenges (2011, background): “Cyanobacteria are a highly diverse group, largely unexplored and untapped therefore, present an opportunity for discovery of novel biochemicals and their use by humankind (Skulberg 2000; Rosenberg et al. 2008).”
Screening of antibacterial activity in marine green, red and brown macroalgae from the western coast of Libya (2013, background): “The potential contribution of marine organisms to the discovery of new bioactive molecules is remarkably increasing [1-3].”